Superoxide Dismutase, BDNF, and Cognitive Improvement in Drug-Naive First-Episode Patients With Schizophrenia: A 12-Week Longitudinal Study

OBJECTIVE: Cognitive improvement after antipsychotic agents in patients with schizophrenia (SCZ) appears to involve redox regulation through neurotrophins such as brain derived neurotropic factor (BDNF). This study examined whether cognitive improvement was associated with the increase in superoxide...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zhiwei, Liu, Qinqin, Zhang, Yinghua, Guan, Xiaoni, Xiu, Meihong, Zhang, Xiangyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Regular Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832226/
https://www.ncbi.nlm.nih.gov/pubmed/34622272
http://dx.doi.org/10.1093/ijnp/pyab065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832226/
https://www.ncbi.nlm.nih.gov/pubmed/34622272
http://dx.doi.org/10.1093/ijnp/pyab065

Ejemplares similares